BIOTOOLS Trademark

Trademark Overview

On Friday, January 28, 2011, a trademark application was filed for BIOTOOLS with the United States Patent and Trademark Office. The USPTO has given the BIOTOOLS trademark a serial number of 79102558. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Wednesday, February 24, 2021. This trademark is owned by BIOTOOLS BIOTECHNOLOGICAL & MEDICAL LABORATORIES, S.A.. The BIOTOOLS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the pharmaceutical and biotechnology fields
biotools

General Information

Serial Number79102558
Word MarkBIOTOOLS
Filing DateFriday, January 28, 2011
Status706 - SECTION 71 ACCEPTED
Status DateWednesday, February 24, 2021
Registration Number4092913
Registration DateTuesday, January 31, 2012
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 15, 2011

Trademark Statements

Pseudo MarkBIO TOOLS
Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 4, 2011
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBIOTOOLS BIOTECHNOLOGICAL & MEDICAL LABORATORIES, S.A.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressMadrid
ES
Party NameBIOTOOLS BIOTECHNOLOGICAL & MEDICAL LABORATORIES, S.A.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressES
Party NameBIOTOOLS BIOTECHNOLOGICAL & MEDICAL LABORATORIES, S.A.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressES

Trademark Events

Event DateEvent Description
Friday, September 30, 2011LIMITATION FROM ORIGINAL APPLICATION ENTERED
Friday, September 30, 2011SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Wednesday, May 30, 2012FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, October 4, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 4, 2011ASSIGNED TO EXAMINER
Friday, October 7, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, October 8, 2011APPLICATION FILING RECEIPT MAILED
Wednesday, October 26, 2011NOTICE OF PUBLICATION
Tuesday, November 15, 2011PUBLISHED FOR OPPOSITION
Tuesday, January 31, 2012REGISTERED-PRINCIPAL REGISTER
Thursday, March 1, 2012GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Wednesday, May 30, 2012FINAL DISPOSITION PROCESSED
Friday, January 5, 2018REGISTERED-SEC.71 ACCEPTED
Friday, September 14, 2012NOTIFICATION PROCESSED BY IB
Thursday, March 17, 2016NEW REPRESENTATIVE AT IB RECEIVED
Thursday, November 10, 2016INTERNATIONAL REGISTRATION RENEWED
Thursday, November 30, 2017TEAS SECTION 71 RECEIVED
Thursday, December 28, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, January 5, 2018NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Sunday, January 31, 2021COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Wednesday, February 3, 2021TEAS SECTION 71 RECEIVED
Tuesday, February 23, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, May 7, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 7, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 24, 2021REGISTERED-SEC.71 ACCEPTED
Wednesday, February 24, 2021NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Monday, July 24, 2023NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, May 7, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, May 31, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, May 31, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, May 31, 2025TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Saturday, May 31, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

biotools fields biotechnology pharmaceutical development research